Azitra Inc Common Stock (AZTR)

About AZTR

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epid…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

13

Website

azitrainc.com/

Fundamentals

1-day range

$0.1244$0.1291

Market cap

$2.18M

P/E (trailing)

6.22

P/E (forward)

-0.24

EPS (trailing)

$-2.06

Dividend yield

—

Beta

-1.05

Avg. volume

11.92M

Forecasts

2 analyst ratings

Azitra Inc Common Stock Competitors

Chosen by industry and closest market cap.

• AZTR

  Azitra Inc Common Stock

  $0.177

  ▼ 4.84%
  Market cap $2.18MP/E 6.22
  $0.1$1.36
• OGEN

  Oragenics Inc. Common Stock

  $0.5296

  ▼ 0.08%
  Market cap $2.45MP/E 0.56
  $0.4801$1.45
• CDT

  CDT Equity Inc. Common Stock

  $1.69

  ▼ 10.37%
  Market cap $2.54MP/E —
  $1.62$2,928
• MTNB

  Matinas Biopharma Holdings Inc. Common Stock

  $0.1966

  ▼ 1.70%
  Market cap $1.72MP/E —
  $0.178$2.14
• SBFM

  Sunshine Biopharma Inc. Common Stock

  $1.16

  ▼ 8.66%
  Market cap $2.97MP/E —
  $1.01$24.3
• BDRX

  Biodexa Pharmaceuticals plc American Depositary Shs

  $0.8351

  ▼ 7.21%
  Market cap $1.10MP/E —
  $0.8303$59.4
• SXTP

  60 Degrees Pharmaceuticals Inc. Common Stock

  $1.03

  ▼ 2.83%
  Market cap $3.28MP/E —
  $1.01$8.62

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

540.5K

Total value held

$126.5K

Institutional holders

7